Search stocks, ETFs and companies

Covered file

Stock · Nasdaq · CRNX

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals discovers, develops, and commercializes therapeutics for endocrine diseases and endocrine-related tumors.

Identity plus TickerGrove reporting or verified official materials.

1 sourced report attached to this file.

No recent result has completed editorial verification. SEC filings and issuer materials remain available below.

Description: Crinetics Pharmaceuticals, Inc. Form 10-K business description

CompareShare by email

Market price

Market price

Latest quoteOpens Google

Primary sources

Go to the record

Open filings and issuer materials directly before relying on a summary.

SEC filingsCIK 0001658247Investor relationsOfficial issuer site

TickerGrove coverage

Latest on Crinetics Pharmaceuticals, Inc.

Understand the company

Read results with the right frame